JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more episode artwork

EPISODE · Jun 12, 2026 · 21 MIN

JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more

from JAMA Editors' Summary

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, Linda Brubaker, MD, Deputy Editor, and Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for articles published from June 6-12, 2026. Related Content: Audio Highlights

Episode metadata supplied by the publisher feed · Published Jun 12, 2026

Embed this episode

Ready to play

JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more

0:00 21:24

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JAMA Editors' Summary?

This episode is 21 minutes long.

When was this JAMA Editors' Summary episode published?

This episode was published on June 12, 2026.

Can I download this JAMA Editors' Summary episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!